Subtractive hybridisation screen identifies genes regulated by glucose deprivation in human neuroblastoma cells

Brain Research

Volumn 1170, Issue SUPPL.: COMPLETE, 2007, Pages 129-139

  Kobayashi, Kisho ^a,c   Xin, Ying ^a,b   Ymer, Susie I ^a   Werther, George A ^a   Russo, Vincenzo C ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b CHINA MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Gene expression; Glucopenia; Hypoglycaemia; Neuronal cells; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE;

APOPTOSIS; ARTICLE; CELL FATE; CONTROLLED STUDY; ENERGY RESOURCE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC TRANSCRIPTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NEUROBLASTOMA CELL; NEUROPROTECTION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STARVATION; SUBTRACTIVE HYBRIDIZATION; VALIDATION PROCESS;

BLOTTING, NORTHERN; BRAIN; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GENETIC SCREENING; GLUCOSE; HUMANS; HYPOGLYCEMIA; IN SITU HYBRIDIZATION; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS;

EID: 34548535677     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.042     Document Type: Article

References (60)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329 (1993) 977-986
2. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann. Intern. Med. 124 (1996) 379-388
3. Almeida A., Delgado-Esteban M., Bolanos J.P., and Medina J.M. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J. Neurochem. 81 (2002) 207-217
4. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., and Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86 (1996) 263-274
5. Ballesteros J.R., Mishra O.P., and McGowan J.E. Alterations in cerebral mitochondria during acute hypoglycemia. Biol. Neonate 84 (2003) 159-163
6. Boyle P.J. Alteration in brain glucose metabolism induced by hypoglycaemia in man. Diabetologia 40 Suppl 2 (1997) S69-S74
7. Bratton S.B., Lewis J., Butterworth M., Duckett C.S., and Cohen G.M. XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ. 9 (2002) 881-892
8. Bruckner B.A., Ammini C.V., Otal M.P., Raizada M.K., and Stacpoole P.W. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 48 (1999) 422-431
9. Cans C., Passer B.J., Shalak V., Nancy-Portebois V., Crible V., Amzallag N., Allanic D., Tufino R., Argentini M., Moras D., Fiucci G., Goud B., Mirande M., Amson R., and Telerman A. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13892-13897
10. Cavaliere F., D'Ambrosi N., Sancesario G., Bernardi G., and Volonte C. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem. Int. 38 (2001) 199-207
11. Chen Q., Baird S.D., Mahadevan M., Besner-Johnston A., Farahani R., Xuan J., Kang X., Lefebvre C., Ikeda J.-E., Korneluk R.G., and MacKenzie A.E. Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. Genomics 48 (1998) 121-127
12. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., and Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10236-10241
13. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.-W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., and Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158 (2002) 507-517
14. Deng Y., and Wu X. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12050-12055
15. Dormond O., Lejeune F.J., and Ruegg C. Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF/IFN gamma. Anticancer Res. 22 (2002) 3159-3163
16. Fitzgerald M.C., and Flanagan M.A. Characterization and sequence analysis of the human ornithine decarboxylase gene. DNA 8 (1989) 623-634
17. Flores-Diaz M., Higuita J.-C., Florin I., Okada T., Pollesello P., Bergman T., Thelestam M., Mori K., and Alape-Giron A. A cellular UDP-glucose deficiency causes overexpression of glucose/oxygen-regulated proteins independent of the endoplasmic reticulum stress elements. J. Biol. Chem. 279 (2004) 21724-21731
18. Fortin A., Cregan S.P., MacLaurin J.G., Kushwaha N., Hickman E.S., Thompson C.S., Hakim A., Albert P.R., Cecconi F., Helin K., Park D.S., and Slack R.S. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J. Cell Biol. 155 (2001) 207-216
19. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
20. Higashitsuji H., Higashitsuji H., Itoh K., Sakurai T., Nagao T., Sumitomo H., Masuda T., Dawson S., Shimada Y., Mayer R.J., and Fujita J. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cells 8 (2005) 75-87
21. Janet T., Ludecke G., Otten U., and Unsicker K. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J. Neurosci. Res. 40 (1995) 707-715
22. Kang H.T., Ju J.W., Cho J.W., and Hwang E.S. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J. Biol. Chem. 278 (2003) 51223-51231
23. Koonin E.V., Mushegian A.R., Tatusov R.L., Altschul S.F., Bryant S.H., Bork P., and Valencia A. Eukaryotic translation elongation factor 1{gamma} contains a glutathione transferase domain-study of a diverse, ancient protein superfamily using motif search and structural modeling. Protein Sci. 3 (1994) 2045-2054
24. Kuwabara H., Yoneda M., Hayasaki H., Nakamura T., and Mori H. Glucose regulated proteins 78 and 75 bind to the receptor for hyaluronan mediated motility in interphase microtubules. Biochem. Biophys. Res. Commun. 339 (2006) 971-976
25. Larsen G.A., Skjellegrind H.K., Berg-Johnsen J., Moe M.C., and Vinje M.L. Depolarization of mitochondria in isolated CA1 neurons during hypoxia, glucose deprivation and glutamate excitotoxicity. Brain Res. 1077 (2006) 153-160
26. Lim M.S., Adamson A., Lin Z., Perez-Ordonez B., Jordan R.C.K., Tripp S., Perkins S.L., and Elenitoba-Johnson K.S.J. Expression of Skp2, a p27Kip1 ubiquitin ligase, in malignant lymphoma: correlation with p27Kip1 and proliferation index. Blood 100 (2002) 2950-2956
27. Lucas A., Morley R., and Cole T.J. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br. Med. J. 297 (1988) 1304-1308
28. Mammalian Gene Collection Program Team*, Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J.M., and Marra M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. PNAS 99 (2002) 16899-16903
29. Martin L.J. Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7 (2001) 455-478
30. Martin L.J., Chen K., and Liu Z. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J. Neurosci. 25 (2005) 6449-6459
31. Menni F., de Lonlay P., Sevin C., Touati G., Peigne C., Barbier V., Nihoul-Fekete C., Saudubray J.M., and Robert J.J. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 107 (2001) 476-479
32. Nomura M., Shimizu S., Sugiyama T., Narita M., Ito T., Matsuda H., and Tsujimoto Y. 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem. 278 (2003) 2058-2065
33. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Adler R.G., and Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21 (1998) 379-384
34. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., and Andrewes D. Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 22 (1999) 1438-1444
35. Northam E.A., Anderson P.J., Jacobs R., Hughes M., Warne G.L., and Werther G.A. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24 (2001) 1541-1546
36. Oglesbee M.J., Herdman A.V., Passmore G.G., and Hoffman W.H. Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. Clin. Biochem. 38 (2005) 900-904
37. Ouyang Y.B., He Q.P., Li P.A., Janelidze S., Wang G.X., and Siesjo B.K. Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type?. Neurochem. Res. 25 (2000) 661-667
38. Pickering, M.T., Kowalik, T.F., 2005. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25, 746-755.
39. Proud C.G. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269 (2002) 5338-5349
40. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., and Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15 (2001) 3104-3117
41. Realini C., Dubiel W., Pratt G., Ferrell K., and Rechsteiner M. Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 269 (1994) 20727-20732
42. Russell, J.L., Weaks, R.L., Berton, T.R., Johnson, D.G., 2005. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene 25, 867-876.
43. Russo V.C., Kobayashi K., Najdovska S., Baker N.L., and Werther G.A. Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system. Brain Res. 1009 (2004) 40-53
44. Sonenberg N., and Newgard C.B. Protein synthesis: the perks of balancing glucose. Science 293 (2001) 818-819
45. Soulie C., Nicole A., Delacourte A., and Ceballos-Picot I. Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process. Neurosci. Lett. 365 (2004) 1-5
46. Stec I., Wright T., van Ommen G., de Boer P., van Haeringen A., Moorman A., Altherr M., and den Dunnen J. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet. 7 (1998) 1071-1082
47. Takami K., Takuwa N., Okazaki H., Kobayashi M., Ohtoshi T., Kawasaki S., Dohi M., Yamamoto K., Nakamura T., Tanaka M., Nakahara K., Takuwa Y., and Takizawa H. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells. Upregulation of p27kip1 cyclin-dependent kinase inhibitor. Am. J. Respir. Cell Mol. Biol. 26 (2002) 231-238
48. Tanahashi N., Suzuki M., Fujiwara T., Takahashi E.-i., Shimbara N., Chung C.H., and Tanaka K. Chromosomal localization and immunological analysis of a family of human 26S proteasomal ATPases. Biochem. Biophys. Res. Commun. 243 (1998) 229-232
49. Tang Y., Lu A., Aronow B.J., Wagner K.R., and Sharp F.R. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur. J. Neurosci. 15 (2002) 1937-1952
50. Thameem F., Yang X., Permana P.A., Wolford J.K., Bogardus C., and Prochazka M. Evaluation of the microsomal glutathione S-transferase 3 (MGST3) locus on 1q23 as a Type 2 diabetes susceptibility gene in Pima Indians. Hum. Genet. 113 (2003) 353-358
51. Vannucci S.J., Maher F., and Simpson I.A. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. GLIA 21 (1997) 2-21
52. Vergun O., Han Y.Y., and Reynolds I.J. Glucose deprivation produces a prolonged increase in sensitivity to glutamate in cultured rat cortical neurons. Exp. Neurol. 183 (2003) 682-694
53. Verma R., Chen S., Feldman R., Schieltz D., Yates J., Dohmen J., and Deshaies R.J. Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol. Biol. Cell 11 (2000) 3425-3439
54. von der Crone S., Deppe C., Barthel A., Sasson S., Joost H.G., and Schurmann A. Glucose deprivation induces Akt-dependent synthesis and incorporation of GLUT1, but not of GLUT4, into the plasma membrane of 3T3-L1 adipocytes. Eur. J. Cell Biol. 79 (2000) 943-949
55. Wadhwa R., Takano S., Robert M., Yoshida A., Nomura H., Reddel R.R., Mitsui Y., and Kaul S.C. Inactivation of tumor suppressor p53 by Mot-2, a hsp70 family member. J. Biol. Chem. 273 (1998) 29586-29591
56. Wang D., Kranz-Eble P., and De Vivo D.C. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum. Mutat. 16 (2000) 224-231
57. Wen Y., Yang S., Liu R., and Simpkins J.W. Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett. 579 (2005) 4591-4599
58. Wirth B., Brichta L., Schrank B., Lochmuller H., Blick S., Baasner A., and Heller R. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum. Genet. 119 (2006) 422-428
59. Yan L., Nairn A.C., Palfrey H.C., and Brady M.J. Glucose regulates EF-2 phosphorylation and protein translation by a protein phosphatase-2A-dependent mechanism in INS-1-derived 832/13 cells. J. Biol. Chem. 278 (2003) 18177-18183
60. Yenari M.A. Heat shock proteins and neuroprotection. Adv. Exp. Med. Biol. 513 (2002) 281-299